Performance of the Echopen Probe in Its Clinical Use for Pregnancy Follow-up in Senegal

Launched by ECHOPEN FACTORY · Mar 1, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the use of a special ultrasound device called the Echopen Probe to help monitor pregnancies in Senegal, particularly in areas where healthcare resources are limited. The goal is to see if using this portable device during regular check-ups can help healthcare providers detect potential problems for both mothers and their babies, thus improving the quality of care. The World Health Organization recommends that pregnant women have at least one ultrasound before 24 weeks of pregnancy, and this study aims to integrate that into routine check-ups.

To participate in this trial, women must be at least 18 years old and at least 37 weeks pregnant, with their delivery planned at the center conducting the trial. They also need to give their written consent to join. Participants will undergo standard check-ups along with the use of the Echopen Probe, which is designed to be simple and easy to use. It's important to note that women with certain complications or emergencies during delivery, as well as those who might not deliver at the study site, will not be eligible for this trial. Overall, this study hopes to improve pregnancy follow-up care and reduce risks for mothers and their babies in resource-limited settings.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Pregnancy ≥ 37 weeks of amenorrhea
• • Women aged ≥ 18 years old
• • Delivery scheduled to take place in the recruitment center
• • Have given her written informed consent to participate
• Exclusion Criteria:
• • Known fetal morphological abnormality
• • Emergency context during the participant's management
• • Obstetrical work in progress
• • Women anticipating displacement or no delivery at the clinical site